Natividad Neri - Publications

MicroRNA-7 Regulates Migration and Chemoresistance in Non-Hodgkin Lymphoma Cells Through Regulation of KLF4 and YY1.

Journal: Frontiers in oncology

Published: July 29, 2020

A new therapeutic approach in very refractory diffuse large B-cell lymphoma.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 11, 2019

Primary gastric diffuse large B-cell lymphoma: The role of dose-dense chemotherapy.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: October 30, 2018

Regulation of Krüppel-Like Factor 4 (KLF4) expression through the transcription factor Yin-Yang 1 (YY1) in non-Hodgkin B-cell lymphoma.

Journal: Oncotarget

Published: August 20, 2018

Retracted article: Adjuvant radiotherapy in patients with diffuse large B-cell lymphoma in advanced stage (III/IV) improves the outcome in the rituximab era.

Journal: Hematology (Amsterdam, Netherlands)

Published: January 18, 2018

Treatment of Early Stages Hodgkin Lymphoma During Pregnancy.

Journal: Mediterranean journal of hematology and infectious diseases

Published: October 08, 2017

Lymphoma and Pregnancy.

Journal: JAMA oncology

Published: December 16, 2016

Lymphoma and pregnancy.

Journal: Japanese journal of clinical oncology

Published: October 21, 2016

Prolonged Use of Zoledronic Acid (4 Years) Did Not Improve Outcome in Multiple Myeloma Patients.

Journal: Clinical lymphoma, myeloma & leukemia

Published: September 28, 2016

Speckle-Tracking Echocardiography to Detect Cardiac Toxicity in Children Who Received Anthracyclines During Pregnancy.

Journal: Clinical lymphoma, myeloma & leukemia

Published: June 18, 2015

Rituximab as consolidation therapy did not improve outcome in patients with diffuse large B-cell lymphoma at complete response after dose-dense chemotherapy (CHOP-14).

Journal: Cancer biotherapy & radiopharmaceuticals

Published: April 15, 2015

Interferon and low doses of methotrexate versus interferon and retinoids in the treatment of refractory/relapsed cutaneous T-cell lymphoma.

Journal: Hematology (Amsterdam, Netherlands)

Published: January 17, 2015